LOS ANGELES–(BUSINESS WIRE)–A securities class action lawsuit has been filed against D-Wave Quantum, Inc. (“D-Wave” or the “Company”) (NASDAQ: QBTS) on behalf of investors who purchased or otherwise acquired D-Wave Quantum, Inc. securities from February 26, 2026 to August 25, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Fessler v. D-Wave Quantum, Inc. et al., filed on October 15, 2026 in the U.S. District Court California Northern District (Case No. 3:26-cv-11953
Author: sHq_LoGiNz
LOS ANGELES–(BUSINESS WIRE)–A securities class action lawsuit has been filed against D-Wave Quantum, Inc. (“D-Wave” or the “Company”) (NASDAQ: QBTS) on behalf of investors who purchased or otherwise acquired D-Wave Quantum, Inc. securities from February 26, 2026 to August 25, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Fessler v. D-Wave Quantum, Inc. et al., filed on October 15, 2026 in the U.S. District Court California Northern District (Case No. 3:26-cv-11953
COPENHAGEN, Denmark–(BUSINESS WIRE)–Genmab A/S (Nasdaq: GMAB) announced today positive topline results from the global Phase 3 RAINFOL™-02 trial of rinatabart sesutecan (Rina-S®), an investigational folate receptor alpha (FRα)-targeted, topoisomerase I (TOPO1)-inhibitor antibody-drug conjugate (ADC), in patients with platinum-resistant ovarian cancer (PROC) regardless of FRα expression level or prior treatment with mirvetuximab. The trial met its primary endpoint of progression-free survival
COPENHAGEN, Denmark–(BUSINESS WIRE)–Genmab A/S (Nasdaq: GMAB) announced today positive topline results from the global Phase 3 RAINFOL™-02 trial of rinatabart sesutecan (Rina-S®), an investigational folate receptor alpha (FRα)-targeted, topoisomerase I (TOPO1)-inhibitor antibody-drug conjugate (ADC), in patients with platinum-resistant ovarian cancer (PROC) regardless of FRα expression level or prior treatment with mirvetuximab. The trial met its primary endpoint of progression-free survival
TORONTO–(BUSINESS WIRE)–Workers at the Workplace Safety and Insurance Board (WSIB) are shocked at the Ontario government’s decision to further reduce WSIB premium rates for bosses while injured workers continue to face the consequences of long-standing cuts to their compensation and WSIB’s own employees face needless layoffs. “Let’s be clear about who is paying the price for these anti-worker decisions,” said Harry Goslin, president of Ontario Compensation Employees’ Union (OCEU)/CUPE Local 1
TORONTO–(BUSINESS WIRE)–Workers at the Workplace Safety and Insurance Board (WSIB) are shocked at the Ontario government’s decision to further reduce WSIB premium rates for bosses while injured workers continue to face the consequences of long-standing cuts to their compensation and WSIB’s own employees face needless layoffs. “Let’s be clear about who is paying the price for these anti-worker decisions,” said Harry Goslin, president of Ontario Compensation Employees’ Union (OCEU)/CUPE Local 1
LONDON–(BUSINESS WIRE)– Re: Macquarie Bank Ltd Australia. EUR 300,000,000.00 MATURING: 27-Jan-2028 ISIN: XS3280329452 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 27-Oct-2026 TO 27-Jan-2027 HAS BEEN FIXED AT 2.99 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 27-Jan-2027 WILL AMOUNT TO: EUR 2,289,266.67 PER EUR 300,000,000.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: Macquarie Bank Ltd Australia. EUR 300,000,000.00 MATURING: 27-Jan-2028 ISIN: XS3280329452 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 27-Oct-2026 TO 27-Jan-2027 HAS BEEN FIXED AT 2.99 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 27-Jan-2027 WILL AMOUNT TO: EUR 2,289,266.67 PER EUR 300,000,000.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: Nationwide Building Society EUR 1,000,000,000.00 MATURING: 29-Jan-2029 ISIN: XS2986730708 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 27-Oct-2026 TO 27-Jan-2027 HAS BEEN FIXED AT 3.47 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 27-Jan-2027 WILL AMOUNT TO: EUR 8,857,555.56 PER EUR 1,000,000,000.00 DENOMINATION
LONDON–(BUSINESS WIRE)– Re: United Utilities Water Plc GBP 50,000,000.00 MATURING: 21-Nov-2056 ISIN: XS0276148334 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-May-2026 TO 21-Nov-2026 HAS BEEN FIXED AT 3.03 PCT DAY BASIS: ACTUAL/ACTUAL(ISMA) INTEREST PAYABLE VALUE 21-Nov-2026 WILL AMOUNT TO: GBP 757.6 PER GBP 50,000.00 DENOMINATION